EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3&bgr;, and &bgr;-Catenin to Foster Vascular Integrity during Experimental Diabetes

Publisher: Bentham Science Publishers

E-ISSN: 1875-5739|8|2|103-120

ISSN: 1567-2026

Source: Current Neurovascular Research, Vol.8, Iss.2, 2011-05, pp. : 103-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract